8ez1
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Human Ornithine Aminotransferase (hOAT) co-crystallized with its inactivator 3-Amino-4-fluorocyclopentenecarboxylic Acid== | |
- | + | <StructureSection load='8ez1' size='340' side='right'caption='[[8ez1]], [[Resolution|resolution]] 1.91Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[8ez1]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8EZ1 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8EZ1 FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=X8B:(3E,4E)-4-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-3-iminocyclopent-1-ene-1-carboxylic+acid'>X8B</scene>, <scene name='pdbligand=X8H:(1R,3S,4Z)-3-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-4-iminocyclopentane-1-carboxylic+acid'>X8H</scene></td></tr> | |
- | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8ez1 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8ez1 OCA], [https://pdbe.org/8ez1 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8ez1 RCSB], [https://www.ebi.ac.uk/pdbsum/8ez1 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8ez1 ProSAT]</span></td></tr> |
- | [[ | + | </table> |
- | [[ | + | == Disease == |
- | [[Category: Butrin | + | [https://www.uniprot.org/uniprot/OAT_HUMAN OAT_HUMAN] Defects in OAT are the cause of hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:[https://omim.org/entry/258870 258870]. HOGA is a slowly progressive blinding autosomal recessive disorder.<ref>PMID:3375240</ref> <ref>PMID:2793865</ref> <ref>PMID:1612597</ref> <ref>PMID:1737786</ref> <ref>PMID:7887415</ref> <ref>PMID:7668253</ref> |
- | [[Category: Silverman | + | == Function == |
+ | [https://www.uniprot.org/uniprot/OAT_HUMAN OAT_HUMAN] | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Butrin A]] | ||
+ | [[Category: Liu D]] | ||
+ | [[Category: Shen S]] | ||
+ | [[Category: Silverman R]] |
Revision as of 12:44, 22 February 2023
Human Ornithine Aminotransferase (hOAT) co-crystallized with its inactivator 3-Amino-4-fluorocyclopentenecarboxylic Acid
|
Categories: Homo sapiens | Large Structures | Butrin A | Liu D | Shen S | Silverman R